Wyeth and FDA warn professionals about Effexor

Share this article:
Wyeth and the FDA are warning healthcare professionals about an overdose potential for patients taking the antidepressant Effexor. A labeling change states that overdose has occurred predominantly in combination with alcohol and/or other drugs.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.